Skip to main content

AVANOS MEDICAL, INC.

corporate_fare Company Profile

AVANOS MEDICAL, INC.

AVNS·NYSE·Industrial Applications And Services·CIK 0001606498

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions globally. The company is headquartered in Alpharetta, Georgia, and was incorporated in Delaware in 2014. Avanos operates through two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The company has manufacturing facilities in the United States, Mexico, and Canada. The Specialty Nutrition Systems (SNS) segment includes products such as enteral feeding solutions, which feature MIC-KEY® enteral feeding tubes and Corpak® patient feeding solutions. MIC-KEY Products and Corpak Products each accounted for more than 10% of consolidated net sales in the years ended December 31, 2025, 2024, and 2023. This segment also offers neonate solutions, including NeoMed® neonatal and pediatric feeding solutions and Nexus TKO™ anti-reflux needleless connectors. NeoMed Products accounted for more than 10% of consolidated net sales in the years ended December 31, 2025, 2024, and 2023. The Pain Management and Recovery segment provides products aimed at reducing opioid use and aiding patient recovery from surgery.

AVANOS MEDICAL, INC. (NYSE:AVNS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors AVNS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Avanos Medical Schedules Shareholder Vote for $25.00/Share Acquisition
  • Avanos Medical to be Acquired for $25.00/Share in Definitive Merger Agreement
  • Avanos Medical Reports Q1 Results Amidst Pending $1.27B Acquisition by American Industrial Partners
  • Avanos Medical Details Acquisition Communications to Employees and Partners, Confirms $25.00/Share Payout
  • Avanos Medical Postpones Annual Meeting Due to Pending Merger Announcement

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$701.2M
Net Income
-$72.9M
Diluted EPS
-$1.57
Op. Cash Flow
$74.7M
Free Cash Flow
$43.1M
Gross Profit
$353.9M
Operating Income
-$61.6M
Cash & Equivalents
$89.8M
Total Debt
$100.5M
Debt / Equity
0.13×
Net Margin
-10.4%
Shares Outstanding
46.46M sh
Source: 10-K · filed 2026-02-24 · accession 0001606498-26-000004
Browse all tickers starting with A →
$24.93 -0.03% today
52-week range · as of 2026-06-10 $9.3 – $25.49
Market cap
$1.17B
Volume
360.5K (0.3× avg)
3-mo avg 1.3M
Live data · 2026-06-13 05:12 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AVNS - Latest Insights

AVNS
Jun 10, 2026, 5:27 PM EDT
Filing Type: DEFM14A
Importance Score:
8
Price at Filing: $24.98
Real-time Price: $24.93 info
Change: -$0.050 (-0.20%) info
Market Cap: $1.169B info
AVNS
May 05, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $24.70
Real-time Price: $24.93 info
Change: +$0.230 (+0.93%) info
Market Cap: $1.169B info
AVNS
May 05, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $25.45
Real-time Price: $24.93 info
Change: -$0.520 (-2%) info
Market Cap: $1.169B info
AVNS
Apr 14, 2026, 4:23 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $24.63
Real-time Price: $24.93 info
Change: +$0.300 (+1%) info
Market Cap: $1.169B info
AVNS
Apr 14, 2026, 1:59 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $24.65
Real-time Price: $24.93 info
Change: +$0.280 (+1%) info
Market Cap: $1.169B info
AVNS
Apr 14, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $24.44
Real-time Price: $24.93 info
Change: +$0.490 (+2%) info
Market Cap: $1.169B info
AVNS
Apr 14, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $14.18
Real-time Price: $24.93 info
Change: +$10.75 (+76%) info
Market Cap: $1.169B info
AVNS
Mar 12, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.43
Real-time Price: $24.93 info
Change: +$11.50 (+86%) info
Market Cap: $1.169B info
AVNS
Feb 26, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.36
Real-time Price: $24.93 info
Change: +$10.57 (+74%) info
Market Cap: $1.169B info
AVNS
Feb 24, 2026, 4:28 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $13.56
Real-time Price: $24.93 info
Change: +$11.37 (+84%) info
Market Cap: $1.169B info
AVNS
Feb 24, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.23
Real-time Price: $24.93 info
Change: +$9.70 (+64%) info
Market Cap: $1.169B info
AVNS
Jan 13, 2026, 5:28 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.40
Real-time Price: $24.93 info
Change: +$13.53 (+119%) info
Market Cap: $1.169B info